These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 12955676

  • 1. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.
    Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
    [Abstract] [Full Text] [Related]

  • 2. IgA nephropathy and tonsils--an approach from the structure of IgA1 produced by tonsillar lymphocytes.
    Hiki Y, Horie A, Yasuda Y, Iwase H, Sugiyama S.
    Acta Otolaryngol Suppl; 2004 Dec; (555):28-31. PubMed ID: 15768794
    [Abstract] [Full Text] [Related]

  • 3. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H.
    Adv Otorhinolaryngol; 2011 Dec; 72():68-70. PubMed ID: 21865693
    [Abstract] [Full Text] [Related]

  • 4. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients.
    Itoh A, Iwase H, Takatani T, Nakamura I, Hayashi M, Oba K, Hiki Y, Kobayashi Y, Okamoto M.
    Nephrol Dial Transplant; 2003 Jun; 18(6):1108-14. PubMed ID: 12748342
    [Abstract] [Full Text] [Related]

  • 5. Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum.
    Iwanami N, Iwase H, Takahashi N, Kato K, Itoh A, Takatani T, Makita S, Kobayashi Y, Okamoto M, Nakamura S, Hiki Y, Ishii M.
    J Nephrol; 2008 Jun; 21(1):118-26. PubMed ID: 18264945
    [Abstract] [Full Text] [Related]

  • 6. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of the beta1,3- galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy.
    Inoue T, Sugiyama H, Kikumoto Y, Fukuoka N, Maeshima Y, Hattori H, Fukushima K, Nishizaki K, Hiki Y, Makino H.
    Contrib Nephrol; 2007 Mar; 157():120-4. PubMed ID: 17495448
    [Abstract] [Full Text] [Related]

  • 8. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
    Itoh A, Iwase H, Takatani T, Nakamura I, Hayashi M, Kobayashi Y, Hiki Y, Okamoto M.
    J Nephrol; 2005 Mar; 18(5):575-81. PubMed ID: 16299684
    [Abstract] [Full Text] [Related]

  • 9. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
    He L, Peng Y, Liu H, Yin W, Chen X, Peng X, Shao J, Liu Y, Liu F.
    Am J Nephrol; 2013 Mar; 38(4):321-32. PubMed ID: 24107646
    [Abstract] [Full Text] [Related]

  • 10. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
    Wang C, Ye M, Zhao Q, Xia M, Liu D, He L, Chen G, Peng Y, Liu H.
    Am J Nephrol; 2019 Mar; 49(4):307-316. PubMed ID: 30917363
    [Abstract] [Full Text] [Related]

  • 11. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
    Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M.
    J Proteomics; 2013 Oct 30; 92():299-312. PubMed ID: 23891555
    [Abstract] [Full Text] [Related]

  • 12. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.
    Liu H, Peng Y, Liu F, Xiao W, Zhang Y, Li W.
    Inflamm Res; 2011 Sep 30; 60(9):869-78. PubMed ID: 21614556
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy.
    Inoue T, Sugiyama H, Hiki Y, Takiue K, Morinaga H, Kitagawa M, Maeshima Y, Fukushima K, Nishizaki K, Akagi H, Narimatsu Y, Narimatsu H, Makino H.
    Clin Immunol; 2010 Sep 30; 136(3):447-55. PubMed ID: 20538527
    [Abstract] [Full Text] [Related]

  • 14. microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.
    Liu C, Ye MY, Yan WZ, Peng XF, He LY, Peng YM.
    Front Immunol; 2020 Sep 30; 11():563699. PubMed ID: 33324395
    [Abstract] [Full Text] [Related]

  • 15. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
    Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.
    J Biol Chem; 2005 May 13; 280(19):19136-45. PubMed ID: 15728186
    [Abstract] [Full Text] [Related]

  • 16. Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy.
    Nagy J, Brandtzaeg P.
    Scand J Immunol; 1988 Apr 13; 27(4):393-9. PubMed ID: 3129777
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.